Unlike most signalling peptides in the research literature, BPC-157 does not target a single well-characterised receptor
Research shows BPC-157 treatment accelerates healing of transected tendons through promotion of tendon outgrowth, cell survival, and cell migration via regulation of ERK1/2 phosphorylation and downstream targets including c-Fos, c-Jun, and Egr-1key molecules involved in cell growth, migration, and angiogenesis
Quality Assurance & Supplier Commitment We maintain longstanding relationships with leading peptide lyophilizers and raw material suppliers, selected through an exhaustive vetting process that evaluates manufacturing practices, analytical capabilities, and regulatory compliance
They report how the math is described, not a recommended dosing schedule